Omicron Archives | Page 8 of 9 | Be Korea-savvy
New Infections Hit Record 56,431 Cases amid Omicron Surge

New Infections Hit Record 56,431 Cases amid Omicron Surge

SEOUL, Feb. 13 (Korea Bizwire) — South Korea’s daily COVID-19 cases hit a fresh record of 56,431 on Sunday, as the highly transmissible omicron variant continued to spread quickly across the nation. The fresh cases, including 56,297 local infections, raised the country’s total caseload to 1,350,630, according to the Korea Disease Control and Prevention Agency [...]

New COVID-19 Cases Reach Fresh High of 54,941 amid Omicron Surge

New COVID-19 Cases Reach Fresh High of 54,941 amid Omicron Surge

SEOUL, Feb. 12 (Korea Bizwire) — South Korea’s new COVID-19 infections reached a fresh daily high Saturday, as the highly transmissible omicron variant continued to spread fast across the nation. The country reported 54,941 new COVID-19 infections, including 53,797 local cases, raising the total to 1,294,205, according to the Korea Disease Control and Prevention Agency [...]

Virus Cases Soar to Nearly 50,000; New All-time High Expected as Omicron Fears Worsen

Virus Cases Soar to Nearly 50,000; New All-time High Expected as Omicron Fears Worsen

SEOUL, Feb. 9 (Korea Bizwire) — South Korea’s daily COVID-19 infections rose sharply to hit another high of nearly 50,000 on Wednesday amid the fast spread of the highly transmissible omicron variant, with authorities placed on heightened alert expecting yet another all-time high for the following day. The country reported 49,567 new COVID-19 infections, including [...]

AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing with Starting Material

AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing with Starting Material

Heidelberg, Germany, Feb. 8 (Korea Bizwire) – AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded partnership to supply more plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19 vaccine at the company’s Heidelberg facility. According to a recent news release from Pfizer and BioNTech, the companies have started to develop an Omicron-based [...]

Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants and Outlines Initiatives to Address Omicron

Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants and Outlines Initiatives to Address Omicron

WALTHAM, Mass., Jan. 12 (Korea Bizwire) — Adagio Therapeutics, Inc., (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today summarized recent findings reported in three separate publications that show ADG20, its lead monoclonal antibody (mAb), has neutralization activity against the Omicron [...]

Daily Infections Below 4,000 for 5th Day amid Tightened Curbs

Daily Infections Below 4,000 for 5th Day amid Tightened Curbs

SEOUL, Jan. 11 (Korea Bizwire) — South Korea’s daily coronavirus cases stayed below 4,000 for the fifth consecutive day Tuesday amid tightened antivirus restrictions, but concerns linger over a possible resurgence due to the continued spread of the omicron variant. The country added 3,097 new COVID-19 infections, including 2,813 local infections, raising the total caseload [...]